Acceleron Pharma (XLRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | XLRN | AMGN | GILD | CELG | ILMN |
| Company | Acceleron Pharma | Amgen Inc | Gilead Sciences Inc | Celgene Corp | Illumina Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 179.85 | 269.93 | 68.27 | 108.01 | 128.28 |
| High | 179.85 | 270.93 | 68.46 | 108.59 | 128.28 |
| Low | 177.06 | 264.35 | 67.70 | 107.27 | 120.97 |
| Last | 178.75 | 265.51 | 67.75 | 108.24 | 121.16 |
| Change | -0.93 | -1.77 | -0.32 | +0.11 | -5.91 |
| % Change | -0.52% | -0.66% | -0.47% | +0.10% | -4.65% |
| Volume | 7,884,200 | 1,740,100 | 7,717,800 | 191,230,496 | 1,616,800 |
| 20-Day Average Volume | 1,302,050 | 2,348,660 | 6,525,295 | 16,188,930 | 1,618,085 |
| Previous Close | 179.68 | 267.28 | 68.07 | 108.13 | 127.07 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | No | Yes |
| Technicals | |||||
| 20-Day Moving Average | 174.46 | 274.13 | 71.23 | 108.17 | 131.58 |
| 20-Day Raw Stochastic | 84.01% | 4.81% | 1.95% | 63.25% | 0.82% |
| 20-Day Relative Strength | 70.12% | 38.68% | 31.69% | 64.69% | 38.41% |
| Weighted Alpha | +57.78 | +5.78 | -22.75 | +46.30 | -43.03 |
| Today's Opinion | 100% Buy | 40% Sell | 100% Sell | 100% Buy | 56% Sell |
| Previous Opinion | 100% Buy | 40% Sell | 100% Sell | 100% Buy | 56% Sell |
| Last Month's Opinion | 88% Buy | 8% Sell | 40% Sell | 100% Buy | 40% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.26% since 11/12/21 | -1.37% since 04/08/24 | -2.41% since 04/08/24 | -1.97% since 11/13/19 | -6.89% since 04/08/24 |
| Low | 173.17 on 11/16/21 | 264.35 on 04/15/24 | 67.62 on 04/12/24 | 107.27 on 11/20/19 | 120.97 on 04/15/24 |
| High | 179.94 on 11/17/21 | 273.00 on 04/11/24 | 69.95 on 04/09/24 | 110.53 on 11/14/19 | 135.26 on 04/09/24 |
| 1-Month | |||||
| %Chg | +2.88% since 10/19/21 | -1.25% since 03/15/24 | -8.06% since 03/15/24 | +5.14% since 10/18/19 | -5.14% since 03/15/24 |
| Low | 172.25 on 10/20/21 | 264.35 on 04/15/24 | 67.62 on 04/12/24 | 102.40 on 10/21/19 | 120.97 on 04/15/24 |
| High | 179.94 on 11/17/21 | 288.57 on 03/28/24 | 74.28 on 03/21/24 | 110.70 on 11/13/19 | 144.19 on 03/21/24 |
| 3-Month | |||||
| %Chg | +48.97% since 08/19/21 | -13.38% since 01/12/24 | -21.57% since 01/12/24 | +13.63% since 08/20/19 | -12.23% since 01/12/24 |
| Low | 120.20 on 08/20/21 | 264.35 on 04/15/24 | 67.62 on 04/12/24 | 93.41 on 08/23/19 | 120.97 on 04/15/24 |
| High | 189.99 on 09/29/21 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 110.70 on 11/13/19 | 148.19 on 01/31/24 |
| 6-Month | |||||
| %Chg | +44.53% since 05/19/21 | -6.54% since 10/13/23 | -12.75% since 10/13/23 | +14.14% since 05/20/19 | -6.16% since 10/13/23 |
| Low | 113.49 on 07/15/21 | 249.70 on 10/31/23 | 67.62 on 04/12/24 | 89.08 on 07/23/19 | 89.00 on 11/10/23 |
| High | 189.99 on 09/29/21 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 110.70 on 11/13/19 | 148.19 on 01/31/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 10,931,634 | 142,291,856 | 84,353,968 | 77,035,920 | 19,295,338 |
| Shares Outstanding, K | 61,156 | 535,919 | 1,245,077 | 711,714 | 159,255 |
| Annual Sales | 92,520,000 | 28,190,000,000 | 27,116,000,000 | 15,281,000,000 | 4,504,000,000 |
| Annual Net Income | -166,030,000 | 6,717,000,000 | 5,665,000,000 | 4,046,000,000 | -1,161,000,000 |
| Last Quarter Sales | 34,200,000 | 8,196,000,000 | 7,114,000,000 | 4,520,000,000 | 1,122,000,000 |
| Last Quarter Net Income | -70,470,000 | 767,000,000 | 1,429,000,000 | 1,691,000,000 | -176,000,000 |
| 60-Month Beta | 0.13 | 0.58 | 0.19 | 1.41 | 1.19 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.16 on 11/04/21 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 2.99 on 10/31/19 | 0.14 on 02/08/24 |
| Latest Earnings Date | 11/04/21 | 05/02/24 | 04/25/24 | 10/31/19 | 05/02/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 03/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.33 | 10.13 | 10.99 | 146.06 |